Detalhe da pesquisa
1.
SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients.
Diabetologia
; 61(7): 1623-1632, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29679103
2.
Accelerated Progression to Type 1 Diabetes in the Presence of HLA-A*24 and -B*18 Is Restricted to Multiple Islet Autoantibody-Positive Individuals With Distinct HLA-DQ and Autoantibody Risk Profiles.
Diabetes Care
; 41(5): 1076-1083, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545461
3.
HLA-A*24 Carrier Status and Autoantibody Surges Posttransplantation Associate With Poor Functional Outcome in Recipients of an Islet Allograft.
Diabetes Care
; 39(6): 1060-4, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27208324